BMO Capital Keeps Their Hold Rating on Bayer (BAYRY)

BMO Capital analyst Joel Jackson maintained a Hold rating on Bayer (BAYRYResearch Report) today and set a price target of EUR66.00. The company’s shares closed last Thursday at $14.67.

According to TipRanks.com, Jackson is a 5-star analyst with an average return of 15.6% and a 63.2% success rate. Jackson covers the Basic Materials sector, focusing on stocks such as Compass Minerals International, Sociedad Quimica Y Minera SA, and ICL Group.

The word on The Street in general, suggests a Hold analyst consensus rating for Bayer with a $67.54 average price target.

See the top stocks recommended by analysts >>

Based on Bayer’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $14.64 billion and net profit of $3.29 billion. In comparison, last year the company earned revenue of $12.33 billion and had a net profit of $2.09 billion.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The CropScience segment includes seeds and plant traits, crop protection and nonagricultural pest control. The Animal Health segment offers prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; raw materials for coatings, adhesives and sealants; and by-products of polyether production and of chlorine production and use. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.

Read More on BAYRY:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More